This week, Eli Lilly and Company announced new plans to invest $1 billion into creating a manufacturing plant in Concord, NC. Lilly, a major pharmaceutical manufacturer, will utilize the latest technology at their new plant to produce injectable products and devices and increase the company’s manufacturing capacity.
“Lilly is entering an exciting period of growth and we are committed to delivering innovative medicines to patients around the world,” said Edgardo Hernandez, Senior Vice President and President, Lilly Manufacturing Operations. “Expanding our manufacturing footprint in North Carolina enables us to continue to produce today’s medicines while providing additional capacity to manufacture the medicines of tomorrow. We are pleased to again partner with North Carolina to bring jobs to American workers and provide more medicines that patients need to address health challenges.”
The company chose Concord due to its close proximity to universities with strong STEM programs, easy access to major transportation infrastructure and a local workforce with strong specialized manufacturing experience. Lilly expects to create 600 new jobs for highly skilled workers such as scientists, engineers and manufacturing personnel once the facility is completed.
North Carolina Governor Roy Cooper said that Lilly “brings more good jobs to North Carolina from one of our most important industries…”North Carolina has become a premier hub for the world, thanks to our exceptional workforce and commitment to education.”
Over the last five years, Lilly has invested over $4 billion in global manufacturing, including more than $2 billion in the U.S. Additionally, in 2020, Lilly announced a $470 million investment in North Carolina’s Research Triangle Park. This new facility allows for them to start reaping the rewards of their previous investment while also strengthening their relationship with local governments and universities.